Business Update
Biopharmaceutical company announces restructuring of operations and finances
Published in Drug Week, September 9th, 2005
The restructuring has been implemented to enable an enhanced focus by the company on next-generation proteins, to allow for the anticipated transfer of production of proteins and reagents to its collaborative partners and contract manufacturers now that its programs are more mature, and to reduce cash burn.
These actions are supplementary to previously announced actions to reduce executive cash-based compensation for 2005 and capital spending. Upon completion of the restructuring, Neose will have reduced the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2005-09-09)
More Articles from Drug Week
- Cancer Therapy
Two additional sites initiated for phase II ADH-1 trial - Generic Drugs
U.S. FDA approves generic equivalent to topical suspension for fungal infections - HIV/AIDS Therapy
Company updates development of fixed-dose regimen of Truvada and Sustiva - Hemophilia
Data for Advate confirm safety and efficacy in hemophilia A patients - Kidney Disease
Phase III program for ferumoxytol modified in IV iron replacement therapy - Acetylcholine Receptors
Nicotinic receptors analyzed, regulatory roles defined - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
